dihydroalprenolol has been researched along with Cardiomyopathies in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bector, N; Dhalla, NS; Jasmin, G; Nagano, M; Sethi, R; Takeda, N | 1 |
| Billingham, ME; Bristow, MR; Lurie, KG; Masek, M; Minobe, WA | 1 |
2 other study(ies) available for dihydroalprenolol and Cardiomyopathies
| Article | Year |
|---|---|
Alterations in G-proteins in congestive heart failure in cardiomyopathic (UM-X7.1) hamsters.
Topics: Adenosine Diphosphate Ribose; Adenylate Cyclase Toxin; Adenylyl Cyclases; Animals; Cardiomyopathies; Cholera Toxin; Colforsin; Cricetinae; Dihydroalprenolol; Epinephrine; GTP-Binding Proteins; Guanylyl Imidodiphosphate; Heart; Heart Failure; Myocardium; NAD; Norepinephrine; Pertussis Toxin; Sarcolemma; Sodium Fluoride; Virulence Factors, Bordetella | 1994 |
6-Hydroxydopamine mediated cardiotoxicity in rabbits.
Topics: Adenylyl Cyclases; Animals; Cardiomyopathies; Dihydroalprenolol; Female; Heart; Hydroxydopamines; Myocardium; Norepinephrine; Oxidopamine; Rabbits; Sympathectomy, Chemical | 1988 |